Ro 3-0419
Ro 3-0419 is a chemical compound that has been studied for its potential pharmacological effects. It is part of a class of compounds known as benzodiazepines, which are known for their effects on the central nervous system, particularly their ability to modulate the GABA_A receptor.
Pharmacology[edit | edit source]
Ro 3-0419 is a derivative of the benzodiazepine class, which are known to act as positive allosteric modulators of the GABA_A receptor. This receptor is a type of ligand-gated ion channel that, when activated, allows chloride ions to enter the neuron, leading to hyperpolarization and decreased neuronal excitability. Benzodiazepines enhance the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at this receptor, leading to sedative, anxiolytic, muscle relaxant, and anticonvulsant effects.
Chemical Structure[edit | edit source]
The chemical structure of Ro 3-0419 is characterized by the presence of a benzodiazepine core, which is a fusion of a benzene ring and a diazepine ring. The specific substitutions on this core structure can significantly affect the pharmacological properties of the compound.
Research and Development[edit | edit source]
Ro 3-0419 was developed as part of a series of compounds aimed at exploring the structure-activity relationships of benzodiazepines. The goal was to identify compounds with specific therapeutic profiles, such as enhanced anxiolytic effects with reduced sedative properties.
Clinical Applications[edit | edit source]
While Ro 3-0419 itself may not be used clinically, the study of such compounds contributes to the understanding of benzodiazepine pharmacology and the development of new therapeutic agents. Benzodiazepines are widely used in the treatment of anxiety disorders, insomnia, muscle spasms, and seizures.
Safety and Toxicology[edit | edit source]
As with other benzodiazepines, potential side effects of compounds like Ro 3-0419 may include drowsiness, dizziness, and impaired coordination. Long-term use can lead to tolerance, dependence, and withdrawal symptoms upon cessation.
Also see[edit | edit source]
Benzodiazipines[edit source]
- Alprazolam
- Chlordiazepoxide
- Diazepam (Oral)
- Estazolam
- Flurazepam
- Lorazepam
- Midazolam
- Oxazepam
- Quazepam
- Temazepam
- Triazolam
Anticonvulsants Drugs[edit source]
Drug class for Ro 3-0419[edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD